Announcements Trials
Browse Landscape

Phase

Phase 2 38Phase 3 29Phase 1 11Phase 4 4Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 4Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Primary Dysautonomias 1Kidney Diseases 1Hypertension 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × bicalutamide × Clear all
NCT05700903 2026-03-02

ARCH

University of Colorado, Denver

Phase 4 Completed
10 enrolled
Genitourinary

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT00470834 2017-02-27

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

GlaxoSmithKline

Phase 4 Completed
127 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00590213 2008-01-25

COMART

AstraZeneca

Phase 4 Completed
125 enrolled
Genitourinary

Prostatic Neoplasms

NCT00293696 2007-05-08

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Tampere University

Phase 4 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡